Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	304	65	7	9	33	8
Market Cap Growth	2341.96%	881.17%	-29.60%	-71.60%	294.06%	-94.82%
Enterprise Value	202	52	1	2	22	-5
Last Close Price	10.96	6.99	4.05	19.72	72.25	134.47
PS Ratio	-	-	88.98	129.85	565.78	83.05
PB Ratio	2.87	1.39	33.04	3.29	1.67	0.83
P/TBV Ratio	3.12	1.39	33.04	3.29	1.67	0.83
EV/Sales Ratio	-	-	9.94	23.51	367.04	-
Debt / Equity Ratio	0.01	0.01	2.77	0.28	0.01	0.04
Asset Turnover	-	-	0.01	0.01	0.00	0.01
Quick Ratio	14.74	10.38	0.64	1.61	14.46	8.68
Current Ratio	14.80	10.49	0.94	1.90	15.05	9.52
Return on Equity (ROE)	-48.57%	-91.68%	-1268.61%	-159.08%	-91.79%	-61.67%
Return on Assets (ROA)	-31.34%	-49.60%	-228.53%	-81.59%	-51.55%	-33.58%
Return on Capital (ROIC)	-34.13%	-58.21%	-535.50%	-93.32%	-55.06%	-38.00%
Earnings Yield	-8.70%	-33.22%	-293.13%	-192.09%	-41.59%	-97.67%
FCF Yield	-6.14%	-29.91%	-269.92%	-167.86%	-39.10%	-90.07%
Buyback Yield / Dilution	-46.71%	-192.98%	-188.30%	-90.24%	-320.63%	-19.19%

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q